Literature DB >> 2331585

Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.

C H Hoyle1, G E Knight, G Burnstock.   

Abstract

1. Suramin, an inhibitor of several types of ATPase, was investigated for its ability to antagonize responses mediated via P2X-purinoceptors in the guinea-pig urinary bladder and P2Y-purinoceptors in the guinea-pig taenia coli. 2. In isolated strips of bladder detrusor muscle, suramin (100 microM-1 mM) caused a non-competitive antagonism of responses to alpha, beta-methylene ATP with an estimated pA2 of approximately 4.7, and inhibited responses to stimulation of the intramural purinergic nerves, with a similar pA2 value. At a concentration of 10 microM, suramin had little effect, but at a concentration of 1 microM, suramin potentiated responses to alpha,beta-methylene ATP, and potentiated responses to electrical stimulation of intramural purinergic nerves. 3. In isolated strips of taenia coli, in which a standard tone had been induced by carbachol (100 nM), suramin at 100 microM and 1 mM significantly antagonized relaxant responses to ATP (at an EC50 concentration) with an estimated pA2 of 5.0 +/- 0.82 and relaxant responses to electrical stimulation of the intramural non-adrenergic, non-cholinergic inhibitory nerves, either single pulses or trains of 8 Hz for 10 s, with estimated pA2 values of 4.9 +/- 0.93 and 4.6 +/- 1.01, respectively. Suramin had no significant effect at 1 or 10 microM. 4. Suramin, at any of the concentrations tested, did not affect contractile responses to histamine (10 microM) or carbachol (10 microM) in the bladder detrusor preparations. In the taenia coli, suramin did not affect either the relaxant responses to noradrenaline (at an EC50 concentration) or the contractile responses to carbachol (100 nM). 5. Thus, suramin at concentrations above 10 microM blocked actions mediated via P2x- and P2y-purinoceptors in the guinea-pig urinary bladder and taenia coli respectively. Potentiation of purinoceptor-mediated activity was seen only at a low concentration of suramin (1 microM) and only in the urinary bladder (P2x-purinoceptor). For its antagonistic activity suramin did not discriminate between P2X- and P2y-purinoceptors, but it was selective for P2-purinoceptor-mediated activity rather than that mediated via cholinoceptors, adrenoceptors or histamine receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331585      PMCID: PMC1917343          DOI: 10.1111/j.1476-5381.1990.tb12979.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Apamin blocks certain neurotransmitter-induced increases in potassium permeability.

Authors:  B E Banks; C Brown; G M Burgess; G Burnstock; M Claret; T M Cocks; D H Jenkinson
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962

2.  Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump.

Authors:  P A Fortes; J C Ellory; V L Lew
Journal:  Biochim Biophys Acta       Date:  1973-08-22

3.  The action of apamin on guinea-pig taenia caeci.

Authors:  A J Maas; A Den Hertog; R Ras; J Van den Akker
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

4.  Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

Authors:  H Mitsuya; M Popovic; R Yarchoan; S Matsushita; R C Gallo; S Broder
Journal:  Science       Date:  1984-10-12       Impact factor: 47.728

5.  Effect of apamin on the electrical responses of smooth muscle to adenosine 5'-triphosphate and to non-adrenergic, non-cholinergic nerve stimulation.

Authors:  M F Shuba; I A Vladimirova
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.

Authors:  L T Williams; P M Tremble; M F Lavin; M E Sunday
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

7.  The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder.

Authors:  S M Hourani; J A Chown
Journal:  Gen Pharmacol       Date:  1989

8.  Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

Authors:  S Broder; R Yarchoan; J M Collins; H C Lane; P D Markham; R W Klecker; R R Redfield; H Mitsuya; D F Hoth; E Gelmann
Journal:  Lancet       Date:  1985-09-21       Impact factor: 79.321

9.  The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder.

Authors:  L Kasakov; G Burnstock
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

10.  Inhibition of vacuolar H+-ATPases by fusidic acid and suramin.

Authors:  Y Moriyama; N Nelson
Journal:  FEBS Lett       Date:  1988-07-18       Impact factor: 4.124

View more
  121 in total

1.  AMP is a partial agonist at the sheep cardiac ryanodine receptor.

Authors:  L L Ching; A J Williams; R Sitsapesan
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Evidence that the ATP-induced increase in vasomotion of guinea-pig mesenteric lymphatics involves an endothelium-dependent release of thromboxane A2.

Authors:  J Gao; J Zhao; S E Rayner; D F Van Helden
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  ATP-induced endothelium-independent enhancement of lymphatic vasomotion in guinea-pig mesentery involves P2X and P2Y receptors.

Authors:  Jun Zhao; Dirk F van Helden
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

4.  Cibacron blue stimulation of surfactant secretion in rat type II pneumocytes.

Authors:  M Griese; L I Gobran; S A Rooney
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

5.  Purinoceptors mediating relaxation and spasm in the rat gastric fundus.

Authors:  M S Matharu; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  The nucleotide receptors on mouse C2C12 myotubes.

Authors:  R H Henning; A Nelemans; J van den Akker; A den Hertog
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAFV600E inhibitor-resistant metastatic melanoma cells.

Authors:  Shaun Martin; Aleksandra M Dudek-Peric; Abhishek D Garg; Heleen Roose; Seyma Demirsoy; Sofie Van Eygen; Freya Mertens; Peter Vangheluwe; Hugo Vankelecom; Patrizia Agostinis
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

8.  Characterization of the adenosine receptor mediating contraction in rat colonic muscularis mucosae.

Authors:  J J Reeves; J Coates; J E Jarvis; M J Sheehan; P Strong
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve.

Authors:  D J Trezise; I Kennedy; P P Humphrey
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

10.  Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder.

Authors:  S J Bailey; S M Hourani
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.